Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older
Clinical trial NCT05304351 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05304351
- Sponsor
- Curevo Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-02
- Primary completion
- 2026-06-30
- Enrollment
- 1516
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.